CD8A and COVID-19: Ex vivo tetramer-enrichment in HLA-B*15:01+ COVID-19 patients across different disease severity states, from asymptomatic to severe and critical patients, revealed no numerical advantage for the presence of cross-reactive, central memory-like B15/S919-specific CD8+ T cells.